These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 14619697)

  • 1. [Hydrophilic gel matrix tablets for oral administration of drugs].
    Rabisková M; Vostalová L; Medvecká G; Horácková D
    Ceska Slov Farm; 2003 Sep; 52(5):211-7. PubMed ID: 14619697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Natural polymers in the formulation of hydrophilic matrix tablets].
    Sedláková M; Rabisková M; Spilková J
    Ceska Slov Farm; 2006 Jan; 55(1):4-11. PubMed ID: 16502804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral pulsatile delivery systems based on swellable hydrophilic polymers.
    Gazzaniga A; Palugan L; Foppoli A; Sangalli ME
    Eur J Pharm Biopharm; 2008 Jan; 68(1):11-8. PubMed ID: 17888641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
    Müller F
    Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Semisynthetic cellulose derivatives as the base of hydrophilic gel systems].
    Bajerová M; Gajdziok J; Dvorácková K; Masteiková R; Kollár P
    Ceska Slov Farm; 2008 Apr; 57(2):63-9. PubMed ID: 18578415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations.
    Hiremath PS; Saha RN
    Int J Pharm; 2008 Oct; 362(1-2):118-25. PubMed ID: 18640251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Control of drug release from coated parenteral matrix-retard tablets using softening agents].
    Korsatko W; Wabnegg B
    Pharmazie; 1983 Sep; 38(9):608-11. PubMed ID: 6647533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The control of drug release of heavy-soluble, weak basic drugs in matrix tablets using the example of medazepam].
    Zessin G; Fahr F; Mank R
    Pharmazie; 1986 Jan; 41(1):39-42. PubMed ID: 2870512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide).
    Abrahmsén-Alami S; Körner A; Nilsson I; Larsson A
    Int J Pharm; 2007 Sep; 342(1-2):105-14. PubMed ID: 17580107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A flexible technology for modified release of drugs: multi layered tablets.
    Abdul S; Poddar SS
    J Control Release; 2004 Jul; 97(3):393-405. PubMed ID: 15212872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on gynaecological hydrophilic lactic acid preparations, Part 7: use of chitosan as lactic acid carrier in intravaginal tablets (globuli vaginales).
    Małolepsza-Jarmołowska K
    Pharmazie; 2006 Sep; 61(9):780-2. PubMed ID: 17020155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride.
    Rajesh KS; Venkataraju MP; Gowda DV
    Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.